Immune Biosolutions Inc. Company Profile

02:48 EDT 18th June 2019 | BioPortfolio

Immune Biosolutions (IBio) is an innovative biotech company specialized in the discovery and engineering of chicken humanized antibodies that target proteins with a recognized, yet unexploited, therapeutic potential. Through its Nebula Antibody Platform, Immune Biosolutions generates high-value recombinant antibody portfolios against historically difficult targets.

News Articles [871 Associated News Articles listed on BioPortfolio]

Emergent Biosolutions, Inc.: Emergent BioSolutions kündigt FDA-Zulassung für Änderung bei Lagerbedingungen und Produktionsverlagerungen für seinen Cholera-Impfstoff an

GAITHERSBURG, Md., June 05, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) hat heute die Zulassung durch die US-amerikanische Lebensmittel- und Arzneimittel-Überwachungsbehörde "U.S....

Will accelerated Laser PCR benefit time critical molecular tests?

Revolutionising the fundamentals of scientific and medical research. GNA Biosolutions is a Munich-based High-tech engineering firm which has developed instruments, OEM modules, and assays for ultra-fa...

Award Winning Customer Care from DSM BioSolutions

In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Villaume Kal of DSM BioSolutions

Emergent Biosolutions, Inc.: Emergent BioSolutions gibt Genehmigung der Marktzulassung in fünf EU-Ländern für seinen oralen Typhus-Impfstoff bekannt; Ausweitung der Verfügbarkeit in Europa

GAITHERSBURG, Maryland, May 20, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) gab heute bekannt, dass es erfolgreich die Marktzulassung für seinen oralen Typhus-Impfstoff Vivotif .....

The Promise of P.L.E.A.S.E.®- Explanation by Christof Boehler, CEO of Pantec Biosolutions

In this episode of PharmaTelevision News Review, Fintan Walton talks to Christof Boehler, CEO of Pantec Biosolutions AG.

Emergent BioSolutions launches Phase III trial of anthrax vaccine

US-based Emergent BioSolutions has initiated a Phase III clinical trial of its anthrax vaccine AV7909 for post-exposure prophylaxis due to...Read More... The post Emergent BioSolutions launches Phase ...

Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax

Emergent BioSolutions (NYSE:EBS) announced the submission of an application to the U.S. Food and Drug Administration (FDA) for potential emergency use of NuThrax (anthrax vaccine adsorbed with CPG 790...

Pall Corporation expands collaboration agreement with ARTeSYN Biosolutions

Pall Corporation, a global leader in filtration, separation and purification, announced the next step in the collaboration agreement with ARTeSYN Biosolutions, a leading innovator in single-use compon...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Cnj-016 [emergent biosolutions canada inc.]

These highlights do not include all the information needed to use CNJ-016 (vaccinia immune globulin intravenous, human), VIGIV safely and effectively. See full prescribing information for VIGIV. VIGIV...

Prednisone [directrx]


Prednisone [directrx]


Sky-living water mt activition liquid [wings biomedical technology co., ltd.]

Drug fact

PubMed Articles [1687 Associated PubMed Articles listed on BioPortfolio]

Immune rebalancing by oral immunotherapy: A novel method for getting the immune system back on track.

Immune modulating treatments are often associated with immune suppression or an opposing anti-inflammatory paradigm. As such, there is a risk of exposing patients to infections and malignancies. Contr...

Progress in research of influence of gene polymorphisms on immune response.

Genes play an important role in the immune system response, and different gene loci may result in different vaccine immune response rates. This review focuses on the correlation between gene polymorph...

Metabolic regulation of immune responses: new perspective for sepsis research.

Immune metabolism is an emerging highlight in recent years. Revealing the metabolic characteristics of different immune cells in different responses may provide new perspective and direction for the p...

Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release.

Treatment multiple tumors by immune therapy can be achieved by mobilizing both innate and adaptive immunity. The programmed death ligand 1 (PD-L1; or CD274, B7-H1) is a critical "don't find me" signal...

Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14 and CD16 monocytes driving an innate immune response.

Cancer patients receiving antibodies abrogating immune checkpoint pathways may develop a diverse array of immune-related adverse events (irAEs), of which lichenoid dermatitis (LD) is the most common. ...

Clinical Trials [3315 Associated Clinical Trials listed on BioPortfolio]

Mechanisms of Immune Deficiency

1. The purpose of this study is to learn more about the changes in genes, cells and proteins that cause immune deficiency diseases. 2. The early stages of the study will focus on t...

Evaluation of Efficacy and Safety of AGP on Immune Enhancement

We investigated the immune enhancing effects of AGP for Korean participants.

Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immune Checkpoint Inhibitors in Genitourinary Malignancies (CTC Immune Based Biomarkers)

This pilot study purpose of this study is to describe peripheral circulating immune cell profiles at baseline and change on treatment with immune checkpoint inhibitors in renal cell carcin...

Study of the Immune Response to Hepatitis C Virus

The purpose of this study is to investigate the mechanism of a successful immune response to hepatitis C virus (HCV) infection. Currently, it is believed that the immune system is involved...

Immune Effects of Vitamin D in Hemodialysis Patients

The purpose of this study to examine whether vitamin D can reduce the activation of the immune system during dialysis. When activated, the immune cells release certain substances, called ...

Companies [518 Associated Companies listed on BioPortfolio]

Immune Biosolutions Inc.

Immune Biosolutions (IBio) is an innovative biotech company specialized in the discovery and engineering of chicken humanized antibodies that target proteins with a recognized, ye...

Fina Biosolutions LLC

Fina Biosolutions (Rockville, MD) is a privately held company providing technology, laboratory, and consulting services in the field of conjugate vaccines. Chemistry developed by ...

Fina Biosolutions

Fina Biosolutions is a privately-owned R&D biotechnology company located in Rockville, MD. The company provides laboratory services and technology in the field of conjugate vaccin...

Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodyâ€...

Pantec Biosolutions AG

Pantec Biosolutions specializes in precise skin microporation technology. Our proprietary P.L.E.A.S.E.® (Precise Laser EpidermAl SystEm) technology has been developed for:

More Information about "Immune Biosolutions Inc." on BioPortfolio

We have published hundreds of Immune Biosolutions Inc. news stories on BioPortfolio along with dozens of Immune Biosolutions Inc. Clinical Trials and PubMed Articles about Immune Biosolutions Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immune Biosolutions Inc. Companies in our database. You can also find out about relevant Immune Biosolutions Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

Corporate Database Quicklinks

Searches Linking to this Company Record